Literature DB >> 15800371

Artificial neural networks and artificial organisms can predict Alzheimer pathology in individual patients only on the basis of cognitive and functional status.

Massimo Buscema1, Enzo Grossi, David Snowdon, Piero Antuono, Marco Intraligi, Guido Maurelli, Rita Savarè.   

Abstract

Data from several studies have pointed out the existence of a strong correlation between Alzheimer's disease (AD) neuropathology and cognitive state. However, because of their highly complex and nonlinear relationship, it has been difficult to develop a predictive model for individual patient classification through traditional statistical approaches. When exposed to complex data sets, artificial neural networks (ANNs) can recognize patterns, learn the relationship of different variables, and address classification tasks. To predict the results of postmortem brain examinations, we applied ANNs to the Nun Study data set, a longitudinal epidemiological study, which includes annual cognitive and functional evaluation. One hundred seventeen subjects from the study participated in this analysis. We determined how demographic data and the cognitive and functional variables of each subject during the last year of her life could predict the presence of brain pathology expressed as Braak stages, neurofibrillary tangles (NFTs) and neuritic plaques (NPs) count in the neocortex and hippocampus, and brain atrophy. The result of this analysis was then compared with traditional statistical models. ANNs proved to be better predictors than Linear Discriminant Analysis in all experimentations (+ approximately 10% in overall accuracy), especially when assembled in Artificial Organisms (+ approximately 20% in overall accuracy). Demographic, cognitive, and clinical variables were better predictors of tangles count in the neocortex and in the hippocampus when compared to NPs count. These findings strengthen the hypothesis that neurofibrillary pathology may represent the major anatomic substrate of the cognitive impairment found in AD.

Entities:  

Mesh:

Year:  2004        PMID: 15800371      PMCID: PMC1360290          DOI: 10.1385/NI:2:4:399

Source DB:  PubMed          Journal:  Neuroinformatics        ISSN: 1539-2791


  18 in total

1.  Mild cognitive impairment: transition between aging and Alzheimer's disease.

Authors:  R C Petersen
Journal:  Neurologia       Date:  2000-03       Impact factor: 3.109

2.  A brief overview and introduction to artificial neural networks.

Authors:  Massimo Buscema
Journal:  Subst Use Misuse       Date:  2002 Jun-Aug       Impact factor: 2.164

3.  Approximate Statistical Tests for Comparing Supervised Classification Learning Algorithms.

Authors: 
Journal:  Neural Comput       Date:  1998-09-15       Impact factor: 2.026

Review 4.  Artificial neural networks and complex social systems. I. Theory.

Authors:  M Buscema
Journal:  Subst Use Misuse       Date:  1998-01       Impact factor: 2.164

5.  Use of artificial networks in clinical trials: a pilot study to predict responsiveness to donepezil in Alzheimer's disease.

Authors:  Patrizia Mecocci; Enzo Grossi; Massimo Buscema; Marco Intraligi; Rita Savarè; Patrizia Rinaldi; Antonio Cherubini; Umberto Senin
Journal:  J Am Geriatr Soc       Date:  2002-11       Impact factor: 5.562

6.  Alzheimer neuropathologic alterations in aged cognitively normal subjects.

Authors:  D G Davis; F A Schmitt; D R Wekstein; W R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  1999-04       Impact factor: 3.685

7.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

8.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

9.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; William R Markesbery
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

10.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study.

Authors:  D A Snowdon; S J Kemper; J A Mortimer; L H Greiner; D R Wekstein; W R Markesbery
Journal:  JAMA       Date:  1996-02-21       Impact factor: 56.272

View more
  4 in total

Review 1.  [Efficiency of specific neuropsychological and clinical-psychological interventions in old age].

Authors:  G Gatterer
Journal:  Z Gerontol Geriatr       Date:  2007-04       Impact factor: 1.281

2.  New happenings at the NIH.

Authors:  David N Kennedy
Journal:  Neuroinformatics       Date:  2008-07-06

3.  Picture Interpretation Test (PIT) 360°: An Innovative Measure of Executive Functions.

Authors:  Silvia Serino; Francesca Baglio; Federica Rossetto; Olivia Realdon; Pietro Cipresso; Thomas D Parsons; Giacomo Cappellini; Fabrizia Mantovani; Gianluca De Leo; Raffaello Nemni; Giuseppe Riva
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

4.  Neuropathological findings processed by artificial neural networks (ANNs) can perfectly distinguish Alzheimer's patients from controls in the Nun Study.

Authors:  Enzo Grossi; Massimo P Buscema; David Snowdon; Piero Antuono
Journal:  BMC Neurol       Date:  2007-06-21       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.